• 1.

    Reddy YNV, et al. Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease. Eur Heart J 2017; 38:19131923. doi: 10.1093/eurheartj/ehx045

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Martínez-Gallardo R, et al. Congestive heart failure in patients with advanced chronic kidney disease: association with pre-emptive vascular access placement. Nefrologia 2012; 32:206212. doi: 10.3265/Nefrologia.pre2011

    • Search Google Scholar
    • Export Citation
  • 3.

    Locatelli F, et al. Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto. Nephrol Dial Transplant 2000; 15:6980. doi: 10.1093/ndt/15.suppl_5.69 (Transonic Reference #HD9643R)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    MacRae JM. Vascular access and cardiac disease: is there a relationship? Curr Opin Nephrol Hypertens 2006; 15:577582. doi: 10.1097/01.mnh.0000247506.79538.3e (Transonic Reference #HD7382A)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    MacRae JM, et al. Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am J Kidney Dis 2004; 43:1722. doi: 10.1053/j.ajkd.2004.01.016 (Transonic Reference #HD408A)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Basile C, et al. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant 2008; 23:282287. doi: 10.1093/ndt/gfm549 (Transonic Reference #HD7542A)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Agarwal AK. Systemic effects of hemodialysis access. Adv Chronic Kidney Dis 2015; 22:459465. doi: 10.1053/j.ackd.2015.07.003

  • 8.

    Ahearn DJ, Maher JF. Heart failure as a complication of hemodialysis arteriovenous fistula. Ann Intern Med 1972; 77:201204. doi: 10.7326/0003-4819-77-2-201

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Bleyer AJ, et al. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006; 69:22682273. doi: 10.1038/sj.ki.5000446

  • 10.

    Ori Y, et al. The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy. Am J Kidney Dis 2002; 40:745752. doi: 10.1053/ajkd.2002.35685

    • Crossref
    • Search Google Scholar
    • Export Citation

The Relevance of High Flow Arteriovenous Access for the Nephrologist

  • 1 Bhavnish Bucktowarsing, is a board-certified general and interventional nephrologist at Kidney & Hypertension Consultants Inc, in Canton, Ohio.
Restricted access

Forty percent of end stage kidney disease (ESKD) patients have a history of heart failure, and 39% have a history of ischemic disease at baseline [Hemodialysis (HEMO) study]. An arteriovenous (AV) access is the preferred access for dialysis, as it reduces risks of infections and hospitalizations and need for interventions. It is well documented that the creation of AV access can cause or aggravate heart failure (1). Typically, this occurs when an AV access turns into a high flow circuit, with resultant high output cardiac failure. In this article, we explore how the recommended access of choice for

Save